tirzepatide surpass SURPASS-CVOT trial: For patients with high-risk type 2 diabetes, the effect of tirzepatide, a dual agonist of the GLP-1 and glucose-dependent insulinotropic polypeptide receptors, on cardiovascular outcomes is uncertain. Research is summarized Tirzepatide versus insulin glargine as

What to record: Number of bathroom visits per day (daytime and nighttime separately) Approximate volume (small, moderate, large) Any pain, burning, urgency, or incontinence Urine color throughout the day Total daily fluid intake (type and amount) Current tirzepatide dose and how long at this dose All other medications and supplements Blood sugar readings if applicable This data allows your provider to quickly distinguish between harmless metabolic adjustment and something requiring investigation

A clear solution that turns cloudy or discolored should be discarded

Understanding your options and what to expect Delivery timing and how the process works General questions before you decide Natural Supplements That May Support GLP-1 and GIP Several natural compounds and dietary supplements have been investigated for their potential to influence GLP-1 and GIP secretion or activity

CGM Creatine

Why is ApoB better than LDL cholesterol

This industry-sponsored trial analyzed semaglutide's potential in a large cohort of around 18 000 patients